• RESLIZUMAB chembl:CHEMBL2107884 Approved

    Alternate Names:

    SCH55700
    SCH-55700
    CINQAERO
    DCP-835
    DCP 835
    CINQAIR
    CINQUIL
    RESLIZUMAB
    CEP-38072
    SCH 55700
    rxcui:1746889
    chembl:CHEMBL2107884
    chemidplus:241473-69-8

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antiinflammatory agent,anti asthmatic
    (0 More Sources)

    Publications:

  • Interaction Score: 27.34

    Interaction Types & Directionality:
    antagonist (inhibitory)
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name reslizumab ,Cinquil
    Novel drug target Novel Target
    Mechanism of Interaction Interleukin-5 inhibitor

    PMIDs:
    None found